This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Priori, S. G. Articles by Napolitano, C. Search for Related Content PubMed PubMed Citation Articles by Priori, S. G. Articles by Napolitano, C. Related Collections Clinical genetics Genomics Ion channels/membrane transport Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2006;114:360-362.)
© 2006 American Heart Association, Inc.

Editorial

Molecular Underpinning of "Good Luck"

Silvia G. Priori, MD, PhD; Carlo Napolitano, MD, PhD

From Molecular Cardiology, Fondazione Salvatore Maugeri (S.G.P., C.N.), and Department of Cardiology, University of Pavia (S.G.P.), Pavia, Italy.

Correspondence to Silvia G. Priori, MD, PhD, Molecular Cardiology, Fondazione Salvatore Maugeri, Via Ferrata 8, 27100 Pavia, Italy. E-mail spriori@fsm.it

Key Words: Editorials • genes • genetics

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The concept that the phenotype observed in patients affected by inherited arrhythmogenic diseases is determined exclusively by the primary genetic defect, transmitted as a mendelian trait, has been questioned by a substantial body of clinical literature showing that incomplete penetrance and variable expressivity are common features of these diseases.^1,2 Investigations demonstrating genotype–phenotype correlations have provided major advances in the understanding of arrhythmogenic disease.^3–6 These studies defined the average behavior (symptoms, prognosis, and response to therapy) of a population of individuals who carry a mutation in a given disease-related gene. From these studies, we now know, for example, that long-QT syndrome (LQTS) patients with mutations on the HERG gene have greater QT interval prolongation and a more malignant clinical course than LQTS patients with mutations of the KCNQ1 gene and that they are less likely to respond to antiadrenergic therapy.^5,6

Article p 368

These data are extremely helpful in guiding our therapeutic decisions but do not explain why some individuals belonging to a high-risk group remain asymptomatic for their entire lives or why other subjects with a benign clinical profile experience cardiac arrest. The issue of incomplete penetrance is particularly puzzling in Brugada syndrome,^7,8 a disease in which the clinical manifestations can be highly variable within the same family and in which it is the rule, rather the exception, to find close relatives who share the same mutation in the SCN5A gene with different manifestations. While one family member with the mutation may show a completely normal ECG, another may have . . . [Full Text of this Article]

This article has been cited by other articles:

				S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF]